EC
PRME icon

EcoR1 Capital’s Prime Medicine PRME Stock Holding History

EcoR1 Capital’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,543,326
Closed -$8.55M – 37
2025
Q3 		$8.55M Buy
+1,543,326
New +$6.27M 0.41% 23
2025
Q2 		– Sell
-700,000
Closed -$1.39M – 44
2025
Q1 		$1.39M Hold
700,000
– – 0.08% 40
2024
Q4 		$2.04M Hold
700,000
– – 0.08% 52
2024
Q3 		$2.71M Hold
700,000
– – 0.09% 53
2024
Q2 		$3.6M Hold
700,000
– – 0.11% 47
2024
Q1 		$4.9M Buy
+700,000
New +$5.31M 0.12% 52
2023
Q4 		– Sell
-600,000
Closed -$5.72M – 55
2023
Q3 		$5.72M Hold
600,000
– – 0.2% 39
2023
Q2 		$8.79M Hold
600,000
– – 0.23% 36
2023
Q1 		$7.38M Hold
600,000
– – 0.24% 36
2022
Q4 		$11.1M Buy
+600,000
New +$10.8M 0.34% 36

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return